Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
107last 24h
3125last 7d
511● bullish (7d)
311● bearish (7d)
227publishers
Simply Wall St.1d agoneutral
Hims & Hers Health (HIMS) Could Be 85% Undervalued Following The Eli Lilly DealSimply Wall St.1d agoneutral
Hims & Hers Stock After Lilly Weight Loss Drug Deal Has The Bull Case Changed?Simply Wall St.1d agoneutral
Hims & Hers Health (HIMS) Adds FDA Approved Obesity Drugs To Its PlatformInvesting.com2d agobullish
Hims & Hers stock climbs on direct partnership with Eli Lilly for obesity drugsInvestor's Business Daily2d agobullish
Hims & Hers Surges On 'Surprising And Inevitable' Deal With Eli LillyBarrons.com2d agoneutral
Why Hims & Hers Health Stock Was in Dire Need of This Eli Lilly AgreementInvestorsHub2d agoneutral
Eli Lilly Partners With Hims & Hers to Expand Access to Obesity Treatments Through TelehealthMT Newswires2d agoneutral
Eli Lilly, Hims & Hers Health Expand Patient Access to Zepbound, FoundayoBusiness Wire2d agoneutral
Lilly and Hims & Hers expand access to FDA-approved Lilly medicines